‘Viread’ will be recommended for most hepatitis B MDR patients

Published: 2014-10-28 16:25:00
Updated: 2014-10-28 15:01:10

A domestic guideline that recommends exclusive prescription of ‘Viread’ to hepatitis B MDR (multiple drug resistance) patients will be introduced.

The Korean Association for the Study of the Liver (KASL) announced to introduce the guideline at ‘the 20th KASL Autumn Academic Conference and Genera...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.